Occupational Skin Disease in 205 Referred Food Handlers Over 21 Years
Doctor’s Notes · Life in Motion · Evidence Review
Editorial disclosure: The featured scene is an AI-created illustration of a fictional work, home or research setting. It is not a patient, diagnosis, before-and-after image or Dr. Arsy #003 treatment result.
The question behind this paper
This review looks at kitchen, bakery and pastry work. The aim is to preserve the study’s actual population, denominator, design and timepoint so a useful signal does not become a universal claim.
Study snapshot
| Study element | Reported detail |
|---|---|
| Population | 205 referred food handlers: 81 kitchen workers, 79 bakers, 34 pastry workers and 11 food-industry workers |
| Design | Retrospective 21-year occupational-dermatology referral cohort |
| Timepoint | Cases evaluated across the full 21-year study period |
| Key result | Occupational skin disease was diagnosed in 58.1%; irritant contact dermatitis in 22.9%, allergic contact dermatitis in 20.0% and protein contact dermatitis in 15.1% |
How to interpret the result
The diagnostic mix matters because irritant, allergic and protein contact disease require different questions and tests. The 58.1% figure applies only to referred workers, not every bakery or kitchen employee.
Important limitation: This is a selected referral cohort, not prevalence among all food handlers; diagnostic practices and workplace exposures may have changed over 21 years.
Questionnaires, examinations, sensors, patch tests and administrative records answer different questions. A screening or monitoring result can guide the next step, but it does not diagnose the cause of one person’s rash. An association can identify a pattern worth investigating without proving that a single task, material or personal factor caused every event.
Questions a worker, family or clinician can ask next
- What exactly was measured: reported symptoms, visible signs, allergy, sleep movement, work loss or quality of life?
- Which denominator applies to the quoted percentage: everyone invited, respondents, symptomatic people, examined participants or a selectively tested subgroup?
- Did the study compare groups or follow change over time, and what factors could still explain the difference?
- Would clinician examination, occupational-health review or clinician-directed testing change the practical plan?
- What requires prompt medical evaluation, including rapidly spreading redness, drainage, fever, severe pain, breathing symptoms or major loss of function?
Primary and authoritative sources
- Primary medical research record: PubMed PMID 40762177
- Authoritative guidance relevant to this topic
- American Academy of Dermatology: eczema skin-care guidance
PubMed indexing is not NIH endorsement of a study’s interpretation, this article or any product.
Where a cosmetic moisturizer fits
Dr. Arsy #003 is a cosmetic moisturizer for hydration, moisture-barrier support and dry-skin comfort. This study did not test #003, and outside research does not become a product result. #003 is not an eczema medicine and this article makes no treatment, cure, prevention, pediatric-safety or 24-hour claim.
Bottom line
The responsible conclusion is narrow: keep the population, denominator, comparator, timepoint and limitations attached, then use the evidence to ask better clinical and exposure-control questions rather than promise a universal result.